Archive for February, 2011
« Previous Entries Next Entries »More Evidence Links Smoking to Increased ALS Risk – Medscape
Thursday, February 24th, 2011
More Evidence Links Smoking to Increased ALS RiskMedscapeFebruary 24, 2011 — Current and former cigarette smokers are at increased risk of developing the motor neuron disorder amyotrophic lateral sclerosis (ALS), according to one of the largest studies to date to look at the smoking–ALS association. …
Inaugural Faculty Scholar Award recipients announced – News from the University of Massachusetts
Thursday, February 24th, 2011Inaugural Faculty Scholar Award recipients announcedNews from the University of Massachusetts… Placebo-Controlled Trial”; and Dr. Zitzewitz will put the resources toward understanding the molecular mechanism of amyotrophic lateral sclerosis (ALS) in the quest for treatments. Research on faculty advancement and retention has shown that heavy …
Trophos successfully completes phase 1 study for novel cardioprotective … – PipelineReview.com (press release)
Thursday, February 24th, 2011Trophos successfully completes phase 1 study for novel cardioprotective …PipelineReview.com (press release)Trophos is excellently positioned to deliver both on its goals with TRO40303 and with our lead product, olesoxime, in a phase 3 study for the orphan neurological disease of amyotrophic lateral sclerosis as part of the EU funded MitoTarget project. …and more »
Regeneron Pharmaceuticals, Inc. (REGN) Upgraded by RBC Capital Mkts to … – FavStocks
Thursday, February 24th, 2011Regeneron Pharmaceuticals, Inc. (REGN) Upgraded by RBC Capital Mkts to …FavStocksRegeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. …
Trophos successfully completes phase 1 study for novel cardioprotective … – PharmaLive (press release) (subscription)
Thursday, February 24th, 2011Trophos successfully completes phase 1 study for novel cardioprotective …PharmaLive (press release) (subscription)Trophos is excellently positioned to deliver both on its goals with TRO40303 and with our lead product, olesoxime, in a phase 3 study for the orphan neurological disease of amyotrophic lateral sclerosis as part of the EU funded MitoTarget project. …
Exciting virtual technology research extends hope to paralysis patients, as … – HULIQ
Thursday, February 24th, 2011HULIQ Exciting virtual technology research extends hope to paralysis patients, as …HULIQNeuroprosthetics are not yet available as a treatment option, but Moran believes that they will one day help those suffering from spinal cord injury, brainstem stroke or amyotrophic lateral sclerosis, which paralyzes the body while leaving the mind …and more »
Virtual technology offers hope to paralysis patients, prosthetics… – HULIQ
Wednesday, February 23rd, 2011Virtual technology offers hope to paralysis patients, prosthetics…HULIQNeuroprosthetics are not yet available as a treatment option, but Moran believes that they will one day help those suffering from spinal cord injury, brainstem stroke or amyotrophic lateral sclerosis, which paralyzes the body while leaving the mind …
Heather Snell ‘courageous until the very end’ – Paris Star
Wednesday, February 23rd, 2011Heather Snell 'courageous until the very end'Paris StarThey've fundraised close to $300000 for amyotrophic lateral sclerosis (ALS) research. Heather's Hootenanny for Hope, and her unwavering determination, has inspired researchers to continue searching for a cure. Dr. Kathryn Volkening, senior researcher …
The Walk to defeat ALS scheduled for March 19, 2011 – SCNow
Wednesday, February 23rd, 2011The Walk to defeat ALS scheduled for March 19, 2011SCNowAmyotrophic Lateral Sclerosis (ALS) is a motor neuron disease, first described in 1869 by the noted French neurologist Jean-Martin Charcot. Although the cause of ALS is not completely understood, the last decade has brought a wealth of new scientific …and more »
What Is Lou Gehrig’s Disease – AccentedTouch
Wednesday, February 23rd, 2011AccentedTouch What Is Lou Gehrig's DiseaseAccentedTouchLou Gehrig's disease is also known as Amyotrophic lateral sclerosis caused by the degeneration of motor neurons. The individual with the disease will lose the capacity to initiate and control voluntary movement. Lou Gehrig's disease can cause death …
« Previous Entries Next Entries »